I do think volume will accelerate over the course of today as data is expected by Tuesday. Also, there will be anticipation of October 6th building next week I am sure. In regard to ICON. Maybe final data triggers some deal with icon to partner or pay for exclusive rights to Lympro outside of the US?
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links